How has been the historical performance of Cryogenic OGS?

Cryogenic OGS has shown steady growth in net sales and profitability over the past three years, with net sales increasing from 22.02 Cr in Mar'23 to 32.90 Cr in Mar'25, and profit after tax rising from 4.08 Cr to 6.09 Cr. The company maintains a healthy balance sheet with no long-term borrowings and improved cash flow.

Answer:<BR>The historical performance of Cryogenic OGS shows a steady growth in net sales and profitability over the past three years.<BR><BR>Breakdown:<BR>Cryogenic OGS has demonstrated a consistent increase in net sales, rising from 22.02 Cr in Mar'23 to 24.25 Cr in Mar'24, and further to 32.90 Cr in Mar'25. Total operating income mirrored this trend, reaching 32.90 Cr in Mar'25. However, raw material costs also increased significantly, from 11.70 Cr in Mar'23 to 21.26 Cr in Mar'25. The total expenditure, excluding depreciation, rose from 16.37 Cr in Mar'23 to 24.94 Cr in Mar'25, yet the operating profit (PBDIT) improved from 6.34 Cr in Mar'23 to 8.85 Cr in Mar'25. Profit before tax also saw an upward trajectory, increasing from 5.48 Cr in Mar'23 to 8.27 Cr in Mar'25, while profit after tax rose from 4.08 Cr to 6.09 Cr in the same period. The earnings per share (EPS) increased from 3.89 in Mar'23 to 5.8 in Mar'25. On the balance sheet, total assets grew from 23.95 Cr in Mar'23 to 33.73 Cr in Mar'25, with total liabilities also increasing from 23.95 Cr to 33.73 Cr. The company maintained no long-term borrowings, and cash and cash equivalents rose from 8.10 Cr in Mar'23 to 11.07 Cr in Mar'25, indicating a positive cash flow position. Overall, Cryogenic OGS has shown robust growth in sales and profitability, alongside a healthy balance sheet.

Is Cryogenic OGS overvalued or undervalued?

As of October 17, 2025, Cryogenic OGS is considered very expensive and overvalued with a PE ratio of 42.91, despite recent strong stock returns of 17.08% and 22.98% over the past week and month, respectively, making it an unfavorable investment at its current price of 183.00.

As of 17 October 2025, the valuation grade for Cryogenic OGS has moved from does not qualify to very expensive, indicating a significant shift in its perceived value. The company is currently overvalued based on its key financial ratios, including a PE ratio of 42.91, an EV to EBITDA ratio of 29.49, and a Price to Book Value of 5.23. <BR><BR>When compared to its peers, Cryogenic OGS stands out with a higher PE ratio than Thermax at 55.98 and BEML Ltd at 61.47, both of which are also classified as very expensive. The company has shown strong returns over the past week and month, outperforming the Sensex with a stock return of 17.08% and 22.98%, respectively. However, despite these short-term gains, the overall valuation suggests that Cryogenic OGS is not a favorable investment at its current price of 183.00.

Which are the latest news on Cryogenic OGS?

Why is Cryogenic OGS falling/rising?

As of 04-Dec, Cryogenic OGS Ltd's stock price is at 175.75, down 5.0% and significantly underperforming compared to the Sensex. The stock has seen a 19.01% decline over the past month, with reduced investor participation and bearish short-term trends contributing to its downward movement.

As of 04-Dec, Cryogenic OGS Ltd's stock price is falling, currently at 175.75, which represents a decrease of 9.25 or 5.0%. The stock has underperformed compared to the benchmark Sensex, which has only seen a decline of 0.53% over the past week, while Cryogenic OGS has dropped by 5.03%. Over the past month, the stock has experienced a significant decline of 19.01%, contrasting sharply with the Sensex's increase of 2.16%.<BR><BR>Today's trading indicates a continuation of this downward trend, as the stock has been losing for the last two days, accumulating a total decline of 6.52% during this period. Although the stock opened with a gain of 2.54% today and reached an intraday high of Rs 191.6, it ultimately fell to a day's low of Rs 175.75, reflecting a 5% decrease. The weighted average price suggests that more volume was traded closer to this low price, indicating a lack of buying interest.<BR><BR>Additionally, there has been a notable decline in investor participation, with delivery volume dropping by 65.6% compared to the 5-day average, further contributing to the stock's downward movement. While the stock is trading above its 100-day and 200-day moving averages, it remains below its 5-day, 20-day, and 50-day moving averages, suggesting a bearish short-term trend. Overall, these factors collectively explain the current decline in Cryogenic OGS Ltd's stock price.